Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-27T05:30:36.098Z Has data issue: false hasContentIssue false

First report of a percutaneous valve-in-Valve implantation of tricuspid valve in a systemic right ventricle

Published online by Cambridge University Press:  31 January 2022

Zeeshan Ahmed Mumtaz
Affiliation:
Department of Pediatric Cardiology, Institute of Cardio Vascular Diseases, Madras Medical Mission, Chennai 600037, India
Sreeja Pavithran
Affiliation:
Department of Pediatric Cardiology, Institute of Cardio Vascular Diseases, Madras Medical Mission, Chennai 600037, India
Kothandam Sivakumar*
Affiliation:
Department of Pediatric Cardiology, Institute of Cardio Vascular Diseases, Madras Medical Mission, Chennai 600037, India
*
Address for correspondence: Dr K. Sivakumar MD DM, Head of Department of Pediatric Cardiology, Institute of Cardio Vascular Diseases, Madras Medical Mission, 4A, Dr J J Nagar, Mogappair, Chennai, 600037, India. Phone +91 944444 49966; Fax +914426565859. Email [email protected]

Abstract

Severe tricuspid regurgitation in corrected transposition of great arteries is treated with early bioprosthetic replacement to prevent right ventricular failure. When bioprosthesis degenerates, surgery on cardioplegic arrest further complicates right ventricular function. We report the first transcatheter valve-in-valve implantation of tricuspid valve in a systemic right ventricle in corrected transposition describing the modifications due to anatomical differences in these patients.

Type
Brief Report
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Prieto, L, Hordof, A, Secic, M, Rosenbaum, M, Gersony, W. Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation 1998; 98: 9971005.CrossRefGoogle ScholarPubMed
Baumgartner, H, De Backer, J, Babu-Narayan, S, et al. ESC guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42: 563645.CrossRefGoogle ScholarPubMed
Koolbergen, D, Ahmed, Y, Bouma, B, et al. Follow-up after tricuspid valve surgery in adult patients with systemic right ventricles. Eur J Cardiothorac Surg 2016; 50: 456463.CrossRefGoogle ScholarPubMed
Bapat, V. Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention 2014; 10 Suppl U: U4451.CrossRefGoogle Scholar
Picard, F, Tadros, V, Asgar, A. From tricuspid to double orifice morphology: percutaneous tricuspid regurgitation repair with the MitraClip device in congenitally corrected-transposition of great arteries. Catheter Cardiovasc Interv 2016; 90: 432436.CrossRefGoogle ScholarPubMed
Luedike, P, Riebisch, M, Weymann, A, Ruhparwar, A, Rassaf, T, Mahabadi, A. Feasibility of a novel transcatheter valve repair system to treat tricuspid regurgitation in ccTGA. J Am Coll Cardiol Case Rep 2021; 3: 893896.Google ScholarPubMed
Guerrero, M, Salinger, M, Pursnani, A, et al. Transseptal transcatheter mitral valve-in-valve: a step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv 2017; 92: E185E196.CrossRefGoogle ScholarPubMed
Sivaprakasam, MC, Reddy, RV, Sengottuvelu, G, Sivakumar, K, et al. Early multicentre experience of a new balloon expandable MyVal transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits. Ann Pediatr Cardiol 2021; 14: 293301.Google Scholar
Supplementary material: Image

Mumtaz et al. supplementary material

Mumtaz et al. supplementary material

Download Mumtaz et al. supplementary material(Image)
Image 13.9 MB